Pro-oxidant effect of transforming growth factor-β1 mediates contractile dysfunction in rat ventricular myocytes

Cardiovascular Research

Volumn 77, Issue 1, 2008, Pages 107-117

  Li, Shumin ^a   Li, Xun ^a,b   Zheng, Hong ^a   Xie, Bin ^a   Bidasee, Keshore R ^c   Rozanski, George J ^a,d  

^a NEBRASKA MEDICAL CENTER   (United States)

^b SOOCHOW UNIVERSITY   (China)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

Glutathione; NAD(P)H oxidase; Oxidative stress; Redox; TGF

Indexed keywords

ACETYLCYSTEINE; CELL PROTEIN; GLUTATHIONE; GLUTATHIONE REDUCTASE; REACTIVE OXYGEN METABOLITE; SCAVENGER; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONFOCAL MICROSCOPY; CONTRACTILE DYSFUNCTION; FLUORESCENCE MICROSCOPY; HEART FUNCTION; HEART MUSCLE CELL; HEART VENTRICLE MUSCLE FIBER; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ANIMALS; CALCIUM; GLUTATHIONE; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; NADPH OXIDASE; OXIDATIVE STRESS; RATS; REACTIVE OXYGEN SPECIES; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; TRANSFORMING GROWTH FACTOR BETA1; VENTRICULAR FUNCTION;

EID: 38849104982     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvm022     Document Type: Article

References (43)

1. Sawyer DB, Siwik DA, Xiao L, Pimentel DR, Singh K, Colucci WS. Role of oxidative stress in myocardial hypertrophy and failure. J Mol Cell Cardiol 2002;34:379-388.
2. Dhalla NS, Temsah RM, Netticadan T. Role of oxidative stress in cardiovascular diseases. J Hypertens 2000;18:655-673.
3. Finkel T. Redox-dependent signal transduction. FEBS Lett 2000;476:52-54.
4. Attisano L, Wrana JL. Signal transduction by the TGF-β1 superfamily. Science 2002;296:1646-1647.
5. White AC, Das SK, Fanburg BL. Reduction of glutathione is associated with growth restriction and enlargement of bovine pulmonary artery endothelial cells produced by transforming growth factorβ1. Am J Respir Cell Mol Biol 1992;6:364-368.
6. Arsalane K, Dubois CM, Muanza T, Begin R, Boudreau F, Asselin C et al. Transforming growth factor-β1 is a potent inhibitor of glutathione synthesis in the lung epithelial cell line A549: transcriptional effect on the GSH rate-limiting enzyme γ-glutamylcysteine synthetase. Am J Respir Cell Mol Biol 1997;17:599-607.
7. Sanchez A, Alvarez AM, Benito M, Fabregat I. Cycloheximide prevents apoptosis, reactive oxygen species production, and glutathione depletion induced by transforming growth factor β in fetal rat hepatocytes in primary culture. Hepatology 1997;26:935-943.
8. Cucoranu I, Clempus R, Dikalova A, Phelan PJ, Ariyan S, Dikalov S et al. NAD(P)H oxidase 4 mediates transforming growth factor-β1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ Res 2005;97:900-907.
9. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology disease. Circ Res 2000;86:494-501.
10. Azhar M, Schultz Jo EJ, Grupp I, Dorn GW II, Meneton P, Molin Daniel GM et al. Transforming growth factor beta in cardiovascular development and function. Cytokine Growth Factor Rev 2003;14:391-407.
11. Doi K, Sawada F, Toda G, Yamachika S, Seto S, Urata Y et al. Alteration of antioxidants during the progression of heart disease in streptozotocin-induced diabetic rats. Free Radic Res 2001;34:251- 261.
12. Kuwahara F, Kai H, Tokuda K, Kai M, Takeshita A, Egashira K et al. Transforming growth factor function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation 2002;106:130-135.
13. Okada H, Takemura G, Kosai K, Li Y, Takahashi T, Esaki M et al. Postinfarction gene therapy against transforming growth factor-β signal modulates infarct tissue dynamics and attenuates left ventricular remodeling and heart failure. Circulation 2005;111:2430-2437.
14. Li S, Li X, Rozanski GJ. Regulation of glutathione in cardiac myocytes. J Mol Cell Cardiol 2003;35:1145-1152.
15. + channel remodeling in postinfarction rat heart. Am J Physiol Heart Circ Physiol 2002;282:H2346-H2355.
16. Heinle H, Brehme U, Friedemann G, Frey JC, Wolf AT, Kelber O et al. Intimal plaque development and oxidative stress in cholesterol-induced atherosclerosis in New Zealand rabbits. Acta Physiol Scand 2002;76:101-107.
17. Carlberg I, Mannervik B. Glutathione reductase. Methods Enzymol 1985;113:484-490.
18. Seelig GF, Meister A. Glutathione synthesis: γ-glutamylcysteine synthetase from rat kidney. Methods Enzymol 1985;113:379-390.
19. 2-generating NADH oxidase in human lung fibroblasts by transforming growth factor-β1. J Biol Chem 1995;270:30334-30338.
20. Li S, Li X, Li YL, Shao CH, Bidasee KR, Rozanski GJ. Insulin regulation of glutathione and contractile phenotype in diabetic rat ventricular myoyctes. Am J Physiol Heart Circ Physiol 2007;292:H1619-H1629.
21. 2+ release in myocytes from streptozotocin-induced diabetic rats. J Mol Cell Cardiol 2007;42:234-246.
22. Agrotis A, Kalinina N, Bobik A. Transforming growth factor-beta, cell signaling and cardiovascular disorders. Curr Vasc Pharmacol 2005;3:55-61.
23. Bujak M, Frangogiannis NG. The role of TGF-β signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res 2007;74:184- 195.
24. Ikeuchi M, Tsutsui H, Shiomi T, Matsusaka H, Matsushima S, Wen J et al. Inhibition of TGF-β signaling exacerbates early cardiac dysfunction but prevents late remodeling after infarction. Cardiovasc Res 2004;64:526-535.
25. Li JM, Fan LM, Christie MR, Shah AM. Acute tumor necrosis factor alpha signaling via NADPH oxidase in microvascular endothelial cells: role of p47phox phosphorylation and binding to TRAF4. Mol Cell Biol 2005;25:2320- 2330.
26. Touyz RM, Yao G, Quinn MT, Pagano PJ, Schiffrin EL. p47phox associates with the cytoskeleton through cortactin in human vascular smooth muscle cells: role in NAD(P)H oxidase regulation by angiotensin II. Arterioscler Thromb Vasc Biol 2005;25:512-518.
27. De Keulenaer GW, Alexander RW, Ushio-Fukai M, Ishizaka N, Griendling KK. Tumor necrosis factor-α activates a p22phox-based NADH oxidase in vascurlar smooth muscle cells. Biochem J 329:653-657. 198.
28. Pagano PJ, Chanock SJ, Siwik DA, Colucci WS, Clark JK. Angiotensin II induces p67phox mRNA expression and NADPH oxidase superoxide generation in rabbit aortic adventitial fibroblasts. Hypertension 1998;32:331- 337.
29. Meister A, Anderson ME. Glutathione. Ann Rev Biochem 1983;52:711-760.
30. Rahman I, MacNee W. Oxidative stress and regulation of glutathione in lung inflammation. Eur Respir J 2000;16:534-554.
31. Herrera B, Murillo MM, Álvarez-Barrientos A, Beltrán J, Fernández M, Fabreggen I. Source of early reactive oxygen species in the apoptosis induced by transforming growth factor-́ in fetal rat hepatocytes. Free Radic Biol Med 2004;36:16-26.
32. Hahn R, Wendel A, Flohe L. The fate of extracellular glutathione in the rat. Biochim Biophys Acta 1978;539:324-337.
33. Bernard GR, Swindell BB, Meredith MJ, Carroll FE, Higgins SB. Glutathione (GSH) repletion by N-acetylcysteine (NAC) in patients with the adult respiratory distress syndrome (ARDS). Am Rev Respir Dis 1989;139:A221.
34. Meurer SK, Lahme B, Tihaa L, Weiskirchen R, Gressner AM. N-Acetyl-L-cysteine suppresses TGF-β signaling at distinct molecular steps: the biochemical and biological efficacy of a multifunctional, antifibrotic drug. Biochem Pharmacol 2005;70:1026-1034.
35. Goldhaber JI, Qayyum MS. Oxygen free radicals and excitation-contraction coupling. Antioxid Redox Signal 2000;2:55-64.
36. Zima AV, Blatter LA. Redox regulation of cardiac calcium channels and transporters. Cardiovasc Res 2006;71:310-321.
37. 2+ handling in heart failure. J Clin Invest 2005;115:556-564.
38. Kourie JI. Interaction of reactive oxygen species with ion transport mechanisms. Am J Physiol 1998;275:C1-C24.
39. Xie H, Zhu PH. Biphasic modulation of ryanodine receptors by sulfhydryl oxidation in rat ventricular myocytes. Biophys J 2006;91:2882- 2891.
40. Kinnear NP, Boittin F-X, Thomas JM, Galione A, Evans AM. Lysosome-sarcoplasmic reticulum junctions. A trigger zone for calcium signaling by nicotinic acid adenine dinucleotide phosphate and endothelin-1. J Biol Chem 2004;279:54319-54326.
41. 2+-ATPase function by direct attack on the ATP binding site. Circ Res 1997;80:76-81.
42. 2+-ATPase activity of cardiac sarcoplasmic reticulum. Arch Biochem Biophys 1988;261:447-457.
43. Vasanji Z, Dhalla NS, Netticadan T. Increased inhibition of SERCA2 by phospholamban in the type I diabetic heart. Mol Cell Biochem 2004;261:245-249.